| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |